Intelect Medical is developing targeted neuromodulation technologies and therapies to improve patient outcomes. Intelect’s neuromodulation technologies include: GUIDE DBS, a deep brain stimulation programming system, conceived of by Cameron McIntyre, Ph.D., Chris Butson, Ph.D. and their colleagues at the Cleveland Clinic and Accupoint DBS leads, the next generation of deep brain stimulation leads. Intelect’s neuromodulation therapies in pre-clinical and clinical research stage include DBS for recovery of chronic stroke patients, based on the work of Andre Machado, M.D. of Cleveland Clinic, and DBS for recovery following traumatic brain injury, based on the work of Nicholas Schiff, M.D., of Weill-Cornell Medical College.